Use of a Novel Fibrin Sealant in Total Knee Arthroplasty

Completed · Phase 2/Phase 3

Conditions studied: Osteoarthritis, Intraoperative Bleeding

In brief

Applying a fibrin spray, after knee device implantation, will help in reducing patient blood loss and decrease the drop in both hemoglobin and hematocrit levels. Also, with decreased blood loss there should be a reduced need for blood transfusions.

Key facts

Study ID

NCT01656759

Run by

Rush University Medical Center

People needed

73

Starts

2012-05-01

Expected to finish

2015-08-01

Last updated by the study team

2016-02-09

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients must be male or female of any race
• Ages 18-80 years old
• Patients must be undergoing an elective, primary knee arthroplasty performed by the principal investigator

You may not qualify if…

• Allergy or intolerance to the study materials
• Surgical intervention during the past month for the treatment of the painful joint or its underlying etiology
• History of previous surgeries on the affected joint including previous arthroscopy (open surgeries)
• Women that are pregnant or may become pregnant
• Patient declines to participate

Where it is running

• Rush Oak Park Hospital — Oak Park, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.